Liebe ICOSIM Mitglieder,
wegen meines Urlaubs ein heute verspätetes ICOSIM-Weekly: Unser CaviTAU-Entwickler Team war vom 19.-21. Mai 2022 in Washington DC.,USA und konnte vor über 100 Teilnehmern die führende Rolle von CaviTAU beim Einsatz von Keramik-Implantaten demonstrieren.
Hier Titel und Abstrakt meines Vortrags in Englisch:
Ultrasonography versus radiography in the assessment of jawbone density in preparation for implant placement- A novel approach
A new ultrasonography device generates an ultrasound wave and passes that wave through the jawbone, called “Trans Alveolar Ultrasonography (TAU)”. Will a newly available TAU device answer the questions:
- Is the jawbone ready for implant insertion?
- Or is the implant connected to persisting bone marrow defects?
- Or connected to aseptic necrotic bone and poses a risk to implant placement?
Ultrasonography device CaviTAU® is developed for the radiation-free measurement of bone density and suitable to visualize the condition of jawbone beyond radiography. TAU device CaviTAU® displays load-free jawbones for non-problematic and durable implant insertion and is available to detect radiographically undetectable “silent inflammations” around persisting “unexplainable painful” implants.
In the daily praxis and for your daily implant success measuring bone density by TAU ultrasonography before and after implantation avoids failures. TAU protects dentists and patients from the early loss of implants. Impressive clinical cases are presented by the presenter.
TAU device CaviTAU® displays a new insight into an under recognized entity of “silent inflammation” in jawbone and is a reliable guide to “jawbone detox”. For further information please visit www.cavitau.de.
Ich wünsche viel Spaß beim Lesen – ich hoffe, es lohnt sich, um weiter Einblick in die völlig neue Fachrichtung einer „Maxillo-mandiblären Osteoimmunology“ zu bekommen –
und verbleibe mit bestem ICOSIM-Gruß
Euer Hans Lechner